Association between metabolic syndrome and sexual dysfunction among men with clinically diagnosed diabetes

Table 3 Prevalence of the various metabolic syndrome risk factors among the study population classified by sexual function

Variable	Total (n = 274)	NSD (n = 84)	SD (n = 190)	P value
WHO
Central Obesity – WHR	210(76.6%)	58(69.0%)	152(80.0%)	0.0482
Raised fasting glucose	274(100.0%)	84(100.0%)	190(100.0%)
Hyperlipidaemia	131(47.8%)	36(42.9%)	95(50.0%)	0.2751
Raised blood pressure	163(59.5%)	47(56.0%)	116(61.1%)	0.4278
NCEP ATP III
Abdominal Obesity – WC	53(19.3%)	13(15.5%)	40(21.1%)	0.2813
Raised fasting glucose	274(100.0%)	84(100.0%)	190(100.0%)
Raised Triglyceride	88(32.1%)	25(29.8%)	63(33.2%)	0.5788
Raised blood pressure	200(73.0%)	54(64.3%)	146(76.8%)	0.0309
Reduced HDL-C	78(28.5%)	21(25.0%)	57(30.0%)	0.3978
IDF
Abdominal Obesity – WC	178(65.0%)	52(61.9%)	126(66.3%)	0.4804
Raised fasting glucose	274(100.0%)	84(100.0%)	190(100.0%)
Raised Triglyceride	88(32.1%)	25(29.8%)	63(33.2%)	0.5788
Raised blood pressure	200(73.0%)	54(64.3%)	146(76.8%)	0.0309
Reduced HDL-C	78(28.5%)	21(25.0%)	57(30.0%)	0.3978

Data are presented as proportion with corresponding percentages in parenthesis. The proportions were compared using Fischer’s exact test.

ISSN: 1758-5996